中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2013年
22期
116-117
,共2页
小儿哮喘%急性发作期%布地奈德混悬液%高剂量%雾化吸入
小兒哮喘%急性髮作期%佈地奈德混懸液%高劑量%霧化吸入
소인효천%급성발작기%포지내덕혼현액%고제량%무화흡입
Pediatric asthma%Acute phase%Budesonide mixed suspension%High dose%Atomization inhalation
目的:探讨对于小儿哮喘急性发作采用高低剂量布地奈德混悬液雾化吸入进行治疗的临床效果。方法:将本院近期收治的75例小儿哮喘急性发作期患儿根据入院先后分为高剂量组(39例)与低剂量组(36例),两组患儿均在常规综合治疗基础之上进行,低剂量组给予布地奈德混悬液0.5 mg/次雾化吸入,高剂量组给予布地奈德混悬液1.0 mg/次,比较两组患儿的临床疗效。结果:两组治疗后24 h、72 h组间比较及各组前后临床表现评分比较差异具有统计学意义(P<0.05),治疗72 h两组PEF、FEV1治疗前后及治疗后组间比较差异具有统计学意义(P<0.05)。结论:对于小儿哮喘急性发作期采用高剂量布地奈德混悬液雾化吸入起效迅速,同时有着较高的安全性,值得在临床上推广使用。
目的:探討對于小兒哮喘急性髮作採用高低劑量佈地奈德混懸液霧化吸入進行治療的臨床效果。方法:將本院近期收治的75例小兒哮喘急性髮作期患兒根據入院先後分為高劑量組(39例)與低劑量組(36例),兩組患兒均在常規綜閤治療基礎之上進行,低劑量組給予佈地奈德混懸液0.5 mg/次霧化吸入,高劑量組給予佈地奈德混懸液1.0 mg/次,比較兩組患兒的臨床療效。結果:兩組治療後24 h、72 h組間比較及各組前後臨床錶現評分比較差異具有統計學意義(P<0.05),治療72 h兩組PEF、FEV1治療前後及治療後組間比較差異具有統計學意義(P<0.05)。結論:對于小兒哮喘急性髮作期採用高劑量佈地奈德混懸液霧化吸入起效迅速,同時有著較高的安全性,值得在臨床上推廣使用。
목적:탐토대우소인효천급성발작채용고저제량포지내덕혼현액무화흡입진행치료적림상효과。방법:장본원근기수치적75례소인효천급성발작기환인근거입원선후분위고제량조(39례)여저제량조(36례),량조환인균재상규종합치료기출지상진행,저제량조급여포지내덕혼현액0.5 mg/차무화흡입,고제량조급여포지내덕혼현액1.0 mg/차,비교량조환인적림상료효。결과:량조치료후24 h、72 h조간비교급각조전후림상표현평분비교차이구유통계학의의(P<0.05),치료72 h량조PEF、FEV1치료전후급치료후조간비교차이구유통계학의의(P<0.05)。결론:대우소인효천급성발작기채용고제량포지내덕혼현액무화흡입기효신속,동시유착교고적안전성,치득재림상상추엄사용。
Objective:To explore for children with asthma acute attack with high and low dose of budesonide suspension liquid atomization inhalation treatment the clinical effect.Method:Our hospital recent treated 75 cases of pediatric asthma children with acute phase according to the hospital,who were divided into the high dose group(39 cases)and low dose group(36 cases),two groups of children were conducted on the basis of routine comprehensive treatment and low dose groups given budesonide suspension liquid atomization inhalation of 0.5 mg/time,high dose group of budesonide suspension liquid for a 1.0 mg/time,compared the clinical curative effect of two groups of children.Result:Two groups of 24 h,72 h after treatment group before and after the rush compared between each group was statistically significant(P<0.05),treatment for 72 h two groups of PEF,FEV1 and components before and after each comparison with statistical difference(P<0.05). Conclusion:For pediatric asthma acute phase using high dose of budesonide suspension liquid atomization inhalation effect quickly,at the same time have higher security,is worth popularizing in clinical use.